Pharmaceutical innovation, competition and patent law : (notice n° 51875)
| 000 -LEADER | |
|---|---|
| fixed length control field | 04190cam a2200457 i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 17621743 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | IMIST |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20190828110512.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130211t20132013enk b 001 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2013932949 |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
| National bibliography number | GBB359380 |
| Source | bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
| Record control number | 016448772 |
| Source | Uk |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780857932457 (hardback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0857932454 (hardback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9780857932464 (e-book) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 0857932462 (e-book) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)ocn852806743 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Uk |
| Language of cataloging | eng |
| Transcribing agency | Uk |
| Description conventions | rda |
| Modifying agency | OCLCO |
| -- | YDXCP |
| -- | IMIST |
| -- | DGW-L |
| -- | AzU |
| -- | DLC |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | lccopycat |
| 043 ## - GEOGRAPHIC AREA CODE | |
| Geographic area code | n-us--- |
| -- | e------ |
| -- | a-ja--- |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | K1519.D78 |
| Item number | P53 2013 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 346.0486 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmaceutical innovation, competition and patent law : |
| Remainder of title | a trilateral perspective / |
| Statement of responsibility, etc | edited by Josef Drexl, Director, Max Planck Institute for Intellectual Property and Competition Law, Munich, Germanyl; Nari Lee, Professor of Intellectual Property Law, Department of Accounting and Commercial Law, Hanken School of Economics, Helsinki. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | viii, 337 pages ; |
| Dimensions | 25 cm |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 00 - FORMATTED CONTENTS NOTE | |
| Title | The patentability of genetic diagnostics in US law and policy / |
| Statement of responsibility | Rochelle C. Dreyfuss -- |
| Title | Patentability of pharmaceutical innovations : the European perspective / |
| Statement of responsibility | Rainer Moufang -- |
| Title | Patentability of medical methods in Japan / |
| Statement of responsibility | Nari Lee -- |
| Title | Patent term restoration and non-patent exclusivity in the US / |
| Statement of responsibility | Margo A. Bagley -- |
| Title | Clinical data, data exclusivity and private investment protection in Europe / |
| Statement of responsibility | Christian R. Fackelmann -- |
| Title | Patent term extension in Japan : an academic and comparative perspective / |
| Statement of responsibility | Ryoko Iseki -- |
| Title | Recent UK case law on supplementary protection certificates / |
| Statement of responsibility | Richard Arnold -- |
| Title | Patent term extension in Japan : focusing on the Pacif Capsule decision / |
| Statement of responsibility | Toshiaki Imura -- |
| Title | Strategic patenting by the pharmaceutical industry : towards a concept of abusive practices of protection / |
| Statement of responsibility | Hanns Ullrich -- |
| Title | Anticompetitive marketing in the context of pharmaceutical switching in Europe / |
| Statement of responsibility | Bengt Domeij -- |
| Title | AstraZeneca and the EU sector inquiry : when do patent filings violate competition law? / |
| Statement of responsibility | Josef Drexl. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drugs |
| Geographic subdivision | United States |
| General subdivision | Patents. |
| 9 (RLIN) | 28360 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drugs |
| Geographic subdivision | European Union countries |
| General subdivision | Patents. |
| 9 (RLIN) | 28361 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drugs |
| Geographic subdivision | Japan |
| General subdivision | Patents. |
| 9 (RLIN) | 28362 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmaceutical industry |
| General subdivision | Technological innovations. |
| 9 (RLIN) | 28363 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Antitrust law |
| Geographic subdivision | European Union countries. |
| 9 (RLIN) | 25645 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Drexl, Josef, |
| Relator term | editor of compilation. |
| 9 (RLIN) | 28364 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lee, Nari, |
| Relator term | editor of compilation. |
| 9 (RLIN) | 28365 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | Table of contents only |
| Uniform Resource Identifier | <a href="http://www.loc.gov/catdir/toc/fy14pdf04/2013932949.html">http://www.loc.gov/catdir/toc/fy14pdf04/2013932949.html</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Livre |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Inventory number | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La bibliothèque des Sciences Juridiques, Economiques et de Gestion | La bibliothèque des Sciences Juridiques, Economiques et de Gestion | 08/28/2019 | 27700 | 346.0486 DRE | 0000000030526 | 08/28/2019 | 08/28/2019 | Livre |
